Buscar
Mostrando ítems 51-60 de 251
Early retinopathy of prematurity findings identified with fluorescein angiography
(2013)
Background: Fluorescein angiography has been fundamental for the understanding and description of vascular disorders affecting the retina and choroid. The aim of this report is to assess the early anatomic retinal changes ...
Early retinopathy of prematurity findings identified with fluorescein angiography
(2013)
Background: Fluorescein angiography has been fundamental for the understanding and description of vascular disorders affecting the retina and choroid. The aim of this report is to assess the early anatomic retinal changes ...
Causas de ceguera infantil en Cali, Colombia.
(2013-10-24)
Introducción: La retinopatía de la prematuridad es la principal causa de ceguera en los niños que consultan a las instituciones
responsables de la atención de este problema en el mundo. En Colombia y en Cali se desconoce ...
Incidencia de la retinopatía de la prematuridad y factores neonatales asociados en el Área Metropolitana de Bucaramanga
(Universidad Autónoma de Bucaramanga UNABFacultad Ciencias de la SaludEspecialización en Oftalmología, 2023-08-16)
Introducción: La retinopatía del prematuro (ROP), inicialmente descrita como fibroplasia retrolental por Terry en 1942, es una de las causas de ceguera irreversible en población pediátrica en países de moderados ingresos, ...
Reduced occurrence of programmed cell death and gliosis in the retinas of juvenile rabbits after shortterm treatment with intravitreous bevacizumab
(Faculdade de Medicina / USP, 2012)
OBJECTIVE: Bevacizumab has been widely used as a vascular endothelial growth factor antagonist in the treatment of retinal vasoproliferative disorders in adults and, more recently, in infants with retinopathy of prematurity. ...
Resultados anatómicos y refractivos en pacientes tratados por retinopatía del prematuro
(Elsevier, 2017)
OBJECTIVE:
To describe the anatomical and refractive outcomes after treatment with intravitreal bevacizumab or laser in a patient cohort with retinopathy of prematurity (ROP).
METHODS:
A multicentre, prospective, and ...
Reduced occurrence of programmed cell death and gliosis in the retinas of juvenile rabbits after short-term treatment with intravitreous bevacizumab
(HOSPITAL CLINICAS, UNIV SAO PAULOSAO PAULO, 2012)
OBJECTIVE: Bevacizumab has been widely used as a vascular endothelial growth factor antagonist in the treatment of retinal vasoproliferative disorders in adults and, more recently, in infants with retinopathy of prematurity. ...
Práctica basada en la evidencia en la experiencia clínica de Neonatología
(Universidad de Valparaíso, 2022)